Novavax (NVAX) FCF Margin Growth (1y) (2011 - 2026)
Novavax (NVAX) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn | 393.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 393.00 |
| Dec 31, 2025 | 16,503.00 |
| Sep 30, 2025 | 32,733.00 |
| Jun 30, 2025 | -14,856.00 |
| Mar 31, 2025 | 6,225.00 |
| Dec 31, 2024 | -14,750.00 |
| Sep 30, 2024 | -12,972.00 |
| Jun 30, 2024 | 11,648.00 |
| Mar 31, 2024 | 31,654.00 |
| Dec 31, 2023 | -3,238.00 |
| Sep 30, 2023 | -2,854.00 |
| Jun 30, 2023 | 4,217.00 |
| Mar 31, 2023 | -39,189.00 |
| Dec 31, 2022 | 12,135.00 |
| Sep 30, 2022 | 7,204.00 |
| Jun 30, 2022 | -12,467.00 |
| Mar 31, 2022 | -16,120.00 |
| Dec 31, 2021 | -9,542.00 |
| Sep 30, 2021 | -7,660.00 |
| Jun 30, 2021 | -27,301.00 |